Cantor Fitzgerald Keeps Their Buy Rating on Cerus (CERS)
Cantor Fitzgerald analyst Ross Osborn maintained a Buy rating on Cerus (CERS) with a price target of $4.00. Osborn, who focuses on the Healthcare sector, has an average return of -6.5% and a 28.81% success rate on his stock recommendations. Cerus also received a Buy rating from Craig-Hallum’s William Bonello recently, while TR | OpenAI reiterated a Hold rating on the stock on October 30.
Cantor Fitzgerald analyst Ross Osborn reiterated a Buy rating on Cerus today and set a price target of $4.00.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Osborn covers the Healthcare sector, focusing on stocks such as Cerus, CVRx, and NeuroPace. According to TipRanks, Osborn has an average return of -6.5% and a 28.81% success rate on recommended stocks.
In addition to Cantor Fitzgerald, Cerus also received a Buy from Craig-Hallum’s William Bonello in a report issued yesterday. However, on October 30, TR | OpenAI – 4o reiterated a Hold rating on Cerus (NASDAQ: CERS).
